ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets
US-based ProFound Therapeutics announced a four-year partnership with Swiss giant Novartis (NYSE: NVS) to discover...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity